Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (1): 42-45.doi: 10.3736/jcim20040116
• Original Experimental Research • Previous Articles Next Articles
Chang-jun Wang1, Jian-jun Li2, Xiao-min Wen3, Li Deng1
CLC Number:
[1] | Freytag SO, Rogulski KR, Paielli DL , et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy[J]. Hum Gene Ther, 1998,9(9):1323-1333 |
[2] | Uckert W, Kammertons T, Haack K , et al. Double suicide gene(cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo[J]. Hum Gene Ther, 1998,9(6):855-865 |
[3] | 许道松, 伍新尧, 钟女奇 , 等. 用融合自杀基因“靶向治疗”CEA阳性肿瘤[J]. 中山医科大学学报, 1998,19(1):79-80 |
[4] | He TC , Zhou S, da Costa LT, et al.A simplified system for generating recombinant adenoviruses[J]. Proc Natl Acad Sci USA, 1998,95(5):2509-2514 |
[5] |
Danthinne X, Werth E . New tools for the generation of E1- and/or E3-substituted adenoviral vectors[J]. Gene Ther, 2000,7(1):80-87
doi: 10.1038/sj.gt.3301047 pmid: 10680020 |
[6] |
Danthinne X . New vectors for the construction of double recombinant adenoviruses[J]. J Virol Methods, 1999,81(1-2):11-20
doi: 10.1016/S0166-0934(99)00054-3 pmid: 10488756 |
[7] | Graham FL, Prevec L . Methods for construction of adenovirus vectors[J]. Mol Biotechnol, 1995,3(3):207-220 |
[1] | Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525. |
[2] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[3] | Tong Zhao, Bing-jie Guo, Chu-lan Xiao, Jiao-jiao Chen, Can Lü, Fan-fu Fang, Bai Li. Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathway. Journal of Integrative Medicine, 2021, 19(5): 418-427. |
[4] | He-tong Zhao, Yong-bin Meng, Xiao-feng Zhai, Bin-bin Cheng, Sha-sha Yu, Man Yao, Hui-xia Yin, Xu-ying Wan, Yun-ke Yang, Hui Liu, Feng Shen, Chang-quan Ling. Comparable effects of Jiedu granules and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study. Journal of Integrative Medicine, 2020, 18(4): 319-325. |
[5] | Porwornwisit Tritripmongkol, Tullayakorn Plengsuriyakarn, Mayuri Tarasuk, Kesara Na-Bangchang. In vitro cytotoxic and toxicological activities of ethanolic extract of Kaempferia galanga Linn. and its active component, ethyl-p-methoxycinnamate, against cholangiocarcinoma. Journal of Integrative Medicine, 2020, 18(4): 326-333. |
[6] | Kai-yue Tang, Shi-lin Du, Qian-lei Wang, Yi-fan Zhang, Hai-yan Song. Traditional chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma. Journal of Integrative Medicine, 2020, 18(3): 196-202. |
[7] | Jeremiah Olorunjuwon Olugbami, Robert Damoiseaux, Bryan France, Michael A. Gbadegesin, Adam Z. Stieg, Shivani Sharma, Oyeronke A. Odunola, James K. Gimzewski. Atomic force microscopy correlates antimetastatic potentials of HepG2 cell line with its redox/energy status: Effects of curcumin and Khaya senegalensis. Journal of Integrative Medicine, 2017, 15(3): 214-230. |
[8] | Xuanbin Wang, Ning Wang, Fan Cheung, Lixing Lao, Charlie Li, Yibin Feng. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: Current progress on pharmacological actions and mechanisms. Journal of Integrative Medicine, 2015, 13(3): 142-164. |
[9] | Yuan-hui Zhang, Yuan Wang, Yusufali Ali Hussein, Frederick Ashby, Daniel Zhang, Zi-fei Yin, George V. Aslanidi, Arun Srivastava, Chang-quan Ling, Chen Ling. Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. Journal of Integrative Medicine, 2014, 12(6): 483-494. |
[10] | Zhi-yi Zhou, Ling Xu, He-gen Li, Jian-hui Tian, Li-jing Jiao, Sheng-fu You, Zhi-fen Han, Yi Jiang, Hui-ru Guo, Hui Liu. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial. Journal of Integrative Medicine, 2014, 12(3): 175-181. |
[11] | Chang-quan Ling, Li-na Wang, Yuan Wang, Yuan-hui Zhang, Zi-fei Yin, Meng Wang, Chen Ling. The roles of traditional Chinese medicine in gene therapy. Journal of Integrative Medicine, 2014, 12(2): 67-75. |
[12] | Wang Li-na, Wang Yuan, Lu Yuan, Yin Zi-fei, Zhang Yuan-hui, V. Aslanidi George, Srivastava Arun, Ling Chang-quan, Ling Chen. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. Journal of Integrative Medicine, 2014, 12(1): 20-34. |
[13] | Hai-yan Song, Li Zhang, Jie-lu Pan, Li-li Yang, Guang Ji. Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of Chinese Integrative Medicine, 2013, 11(4): 262-268. |
[14] | Xiao-feng Zhai, Zhe Chen, Bai Li, Feng Shen, Jia Fan, Wei-ping Zhou, Yun-ke Yang, Jing Xu, Xiao Qin, Le-qun Li, Chang-quan Ling. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: A multicenter randomized controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(2): 90-100. |
[15] | Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640. |
|